1.Abnormal rates of indexes and influencing factors related to chronic diseases of workers in Hangzhou enterprises.
Xian-fu MA ; Qing-min LIU ; Yan-ju REN ; Jun LV ; Li-ming LI
Chinese Journal of Epidemiology 2013;34(10):1049-1050
Adult
;
China
;
epidemiology
;
Chronic Disease
;
epidemiology
;
Dyslipidemias
;
epidemiology
;
Female
;
Health Status
;
Humans
;
Hypertension
;
epidemiology
;
Male
;
Middle Aged
;
Obesity
;
epidemiology
;
Smoking
;
epidemiology
2.Acute toxicity of meso-2,3-dimercaptosuccinic acid on mice
Shi-Jun LIU ; Xue-Hai JU ; Ke-Ming SUN ; Zhi-Jie CHU ; Xian-Yong LIU ; Min ZHANG ; Jun-Qing GUO ;
Chinese Journal of Primary Medicine and Pharmacy 2006;0(08):-
Objective To explore acute toxicity of succimer on mice.Methods Twenty Kunming mice(10 males and 10 females) weighting approximately (21.2?2.3)g were acclimatized for 3 days prior to dosing,then were divided into control group and experiment group with 10 mice in each group according to body weight.Fasted for 12 hours,the mice in experiment group received intragastric administration of 160mg DMSA in deionized water in 24 hours,and the control group received the same volume of deionized water,and then they were observed for 7 days.Blood was collected into heparinized-tubes by removal of eyeball.All mice were sacrificed and brain,heart,liver and kidney were removed and washed with normal saline.The activity or amount of BUN,Scr,AST,ALT,SOD, GSH-PX and MDA were analyzed.Results (1)Given 160rag DMSA in 24 hours,gastrointestinal symptoms were main side effects.During the observation,experiment group lost weight due to the decrease of food-intake ,and some mice had slight hydroabdomen.(2)High dose of DMSA caused a significant inhibition of GSH-PX(P0.05).The hepatic cell was damaged accord- ing to the significant raise of MDA in liver(P0.05),which was related to acute toxicity on liver.Conclusion Succimer could inhibit the antioxidarrt systems and could do damage to liver and kidney.
3.Influence on physiological load of crewmen exposed to noise and noxious substances in compartments during tank gun shooting.
Xiang-yang HAO ; Shao-bo YANG ; Xiang-cheng BAI ; Wei ZHANG ; Jiang-shen XIE ; Hui-xian WANG ; Jian-ju LIU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(8):491-493
4.Expression and significance of B7-H1 and its receptor PD-1 in human gastric carcinoma.
Shu-Man LIU ; Qing MENG ; Qin-Xian ZHANG ; Sheng-Dian WANG ; Zhan-Ju LIU ; Xie-Fu ZHANG
Chinese Journal of Oncology 2008;30(3):192-195
OBJECTIVEThe B7-H1/PD-1 co-signaling pathway has recently been found to play a pivotal role in the immune evasion of tumor cells from host immune system. The aim of this study was to examine the B7-H1 and PD-1 expression and TILs status in gastric cancer and to elucidate the clinical relevance of B7-H1 and PD-1 to the pathogenesis of gastric carcinoma.
METHODSImmunohistochemistry and ANAE histochemical staining were used to investigate the in situ expression of B7-H1 and PD-1 and TILs status in the gastric tissues. RT-PCR was used to explore B7-H1 and PD-1 expression at the transcriptional level. The B7-H1 expression at protein level was detected by Western blot.
RESULTSExpression of B7-H1 and PD-1 was found to be increased in gastric carcinoma, but absent in normal gastric tissue. B7-H1 expression in gastric carcinoma was inversely correlated with TILs infiltration. B7-H1 but not PD-1 expression in tumor tissue was significantly correlated with some clinicopathhological variables including depth of invasion, lymph node metastasis and distant metastasis.
CONCLUSIONB7-H1 and PD-1 expressions are increased in gastric carcinoma. This signaling pathway may inhibit antitumor immune responses in gastric carcinoma. B7-H1 expression plays a critical role in the pathogenesis of human gastric carcinoma,and might be a promising prognostic marker and therapeutic target in the treatment of this disease.
Adult ; Aged ; Antigens, CD ; genetics ; metabolism ; Apoptosis Regulatory Proteins ; genetics ; metabolism ; B7-H1 Antigen ; CD4-Positive T-Lymphocytes ; immunology ; Female ; Humans ; Lymphatic Metastasis ; Lymphocyte Subsets ; immunology ; Lymphocytes, Tumor-Infiltrating ; immunology ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Staging ; Programmed Cell Death 1 Receptor ; RNA, Messenger ; metabolism ; Stomach Neoplasms ; genetics ; immunology ; pathology
5.Down-regulation of TopI by RNA interference reduces the drug-sensitivity of small cell lung cancer cell lines to topotecan.
Xiu-ju LIU ; Qi-sen GUO ; Qiong ZHANG ; Xian-rang SONG ; Yong-lei LIU ; Chen GUO
Chinese Journal of Oncology 2008;30(10):741-744
OBJECTIVETo investigate the expressions of TopI gene in small cell lung cancer cell line H446, and explore the influence of TopI on the chemosensitivity of the cell line to topotecan (TPT).
METHODSWestern blot was performed to detect the TopI expression in H446 cells. Lipofectamine 2000 was used for the transient transfection of H446 cells by siRNA, and the transfection efficacy was detected. TopI mRNA was analyzed by quantitative RT-PCR and TopI protein was detected by Western blot to selected effective siRNA. The drug-sensitivity to topotecan (TPT) was evaluated by MTT assay.
RESULTSTopI gene was expressed in H446 cells. Lipofectamine 2000 mediated the siRNA effectively (88.67%). Compared with its parental cells, RT-PCR results showed that TopI mRNAs in transfected cells were reduced by (95.7 +/- 1.6)%, (90.8 +/- 1.6)%, (96.1 +/- 2.7)% and (96.3 +/- 1.8)%, respectively, and decreased significantly at protein level. By MTT assay, the inhibition rate of TPT to H446 cells transfected by siRNA was lower than that of control group at same concentrations (P < 0.01).
CONCLUSIONsiRNAs can silence the expression of TopI and decrease the drug-sensitivity of H446 cells to TPT.
Antineoplastic Agents ; pharmacology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; DNA Topoisomerases, Type I ; genetics ; metabolism ; Down-Regulation ; Drug Resistance, Neoplasm ; Humans ; Lung Neoplasms ; metabolism ; pathology ; RNA Interference ; RNA, Messenger ; metabolism ; RNA, Small Interfering ; genetics ; Small Cell Lung Carcinoma ; metabolism ; pathology ; Topotecan ; pharmacology ; Transfection
6.Observation on therapeutic effect of warming needle moxibustion on chronic pelvic inflammation of cold-damp stagnation type.
Hong-Liang ZHEN ; Ying WANG ; Xian-Ju LIU
Chinese Acupuncture & Moxibustion 2008;28(10):736-738
OBJECTIVETo observe clinical therapeutic effect of warming needle moxibustion on chronic pelvic in flammation of cold-damp stagnation type.
METHODSEighty-five cases with chronic pelvic inflammation were randomly divided into a warming needle moxibustion group of 45 cases and a Chinese drug group of 40 cases. The war ming needle moxibustion group were treated with warming needle moxibustion at Guanyuan (CV 4), Qihai (CV 6), Zusanli (ST 36) and Shenshu (BL 23) etc. and the Chinese drug group were treated with oral administration of TCM decoction, one dose each day. One course was constituted by 10 days. After treatment of 3 courses, the therapeutic effects, changes of C-reactive protein (CRP) level and the recurrence rate of the cured cases a half year later were observed.
RESULTSThe total effective rate was 95.6% in the warming needle moxibustion group and 77.5% in the Chinese drug group with a significant difference between the two groups (P < 0.05). Twenty-five cases in each group were selected to determine CRP levels and results showed that before and after treatment CRP levels were (16.47 +/- 7.11) mg/L and (5.98 +/- 2.29) mg/L in the warming needle moxibustion group, and (16.32 +/- 8.19) mg/L and (8.63 +/- 2.41) mg/L in the Chinese drug group, with significantly decreased in the two groups (P < 0.01 or P < 0.05), and with a significant difference between the two group after treatment (P < 0.05). In the warming needle moxibustion group, of 23 cases followed-up, 2 cases relapsed, while in the Chinese drug group, among 9 cases followed-up, 2 cases relapsed.
CONCLUSIONWarming needle moxibustion has a definite therapeutic effect on chronic pelvic inflammation of cold-damp stagnation type and better improves CRP level of the patient.
Adult ; C-Reactive Protein ; metabolism ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Moxibustion ; Pelvic Inflammatory Disease ; therapy ; Recurrence ; Thermosensing ; Treatment Outcome
7.Primary obturator foramen pregnancy: a case report and review of literature.
Jing-xian LIN ; Qi LIU ; Yan JU ; Qun GUAN ; Yuan-zhe WU ; Ning ZHENG
Chinese Medical Journal 2008;121(14):1328-1330
8.The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA.
Yi SONG ; Mei-Ju LIU ; Guo-Wei ZHAO ; Jun-Jie QIAN ; Yan DONG ; Hua LIU ; Guo-Jing SUN ; Zhu-Zhong MEI ; Bin LIU ; Bao-Lei TIAN ; Zhi-Xian SUN
Journal of Experimental Hematology 2005;13(2):174-181
To investigate the function and molecular mechanism of p21(WAF1/Cip-1) expression in MOLT-4 cells induced by HDAC inhibitor TSA, the expression pattern of p21(WAF1/Cip-1) and the distribution of cell cycle in TSA treated cells were analyzed. The results showed that TSA could effectively induce G(2)/M arrest and apoptosis of MOLT-4 cells. Kinetic experiments demonstrated that p21(WAF1/Cip-1) were upregulated quickly before cell arrested in G(2)/M and began decreasing at the early stage of apoptosis. Meanwhile, the proteasome inhibitor MG-132 could inhibit the decrease of p21(WAF1/Cip-1) at the early stage of apoptosis, which showed that proteasome pathway involved in p21(WAF1/Cip-1) degradation during the TSA induced G(2)/M arrest and apoptosis responses. This study also identified that the protein level of p21(WAF1/Cip-1) was highly associated with the cell cycle change induced by TSA. Compared to cells treated by TSA only, exposure MOLT-4 cells to TSA meanwhile treatment with MG-132 increased the protein level of p21(WAF1/Cip-1) and increased the numbers of cell in G(2)/M-phase, whereas the cell apoptosis were delayed. It is concluded that p21(WAF1/Cip-1) plays a significant role in G(2)/M arrest and apoptosis signaling induced by TSA in MOLT-4 cells.
Apoptosis
;
drug effects
;
Blotting, Western
;
Cell Cycle
;
drug effects
;
Cell Line, Tumor
;
Cyclin-Dependent Kinase Inhibitor p21
;
biosynthesis
;
Enzyme Inhibitors
;
pharmacology
;
Flow Cytometry
;
Histone Deacetylase Inhibitors
;
Humans
;
Hydroxamic Acids
;
pharmacology
;
Leukemia, Myeloid
;
metabolism
;
pathology
9.Morphological study of adenoid by endoscopy and its clinical significance.
Ju-bo LIU ; Li-ya LIU ; Min-qiang XIE ; Zhi-jian FENG ; Xiang LU ; Xian-hua LI ; Yi-chun HONG ; Yan-qun CHANG ; Li YU
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(6):437-442
OBJECTIVETo observe the natural process of adenoid growth and degeneration as the age grows, to investigate the related clinical significance and pathologic characteristics of hypertrophied adenoid.
METHODSTotally 2650 (age 2 to 87) cases with nasal obstruction or/and other symptoms were included in the patients group, and 810 (age 3 to 85) subjects without symptoms were included as the control group. Morphological characteristics examined with nasal endoscope. Biopsy was performed for 39 cases. The adenoid was calcified as 4 degrees according to the size.
RESULTSIn the patient group, age 2 to 9, degree III and degree II adenoid were 81.1% (198/244) and 18.9% (46/244) respectively. And adenoid of children whose age 2 to 5 was 100.0% in degree III; In above 10 years old group, the adenoid was mostly degree II. In age 60 to 69 group, degree 0 was (66.5%), and in age 81 or above, degree 0 reaches 100%. And 19 years old was the youngest age at which adenoid of degree 0 started to be found and 21 was the oldest age at which there is no adenoid of degree III. In the control group, compared with the patient group, no statistical significant difference found in all other groups except in age 2 to 9 (degree III 57.9%, 22/38, degree II 42.1%, 16/38). Shapes of adenoids at degree II varied while degree I were almost like peeled orange. Pathologically, among children there are abundant of adenoidal lymph tissue, while in adults the lymph tissue getting less as age grows but with evident inflammation reaction. Among patients, the incidence of sinusitis and snoring was higher in degree III group compared with others, 47.4% and 18.7% respectively, and the differences is statistically significant (chi2 = 51.28, P < 0.01; chi2 = 40.26, P < 0.01).
CONCLUSIONSAdenoid volume of children (age < 10) is the biggest, especially of children under 5 years old.
Adenoids ; pathology ; surgery ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Child ; Child, Preschool ; Endoscopy ; Female ; Humans ; Male ; Middle Aged ; Nasal Obstruction ; pathology ; surgery ; Young Adult
10.Prognostic factors in patients with stage III and IV non-small cell lung cancer.
Li-hua SONG ; Xian-rang SONG ; Mei-qin LIU ; Xi-qin ZHANG ; Li ZHENG ; Xiu-ju LI ; Pu-xiang LIU
Chinese Journal of Oncology 2004;26(6):345-348
OBJECTIVETo investigate the prognostic factors in non-small cell lung cancer (NSCLC) at stage III and IV and establish a reliable model of clinical prognostic index.
METHODSKaplan-Meier and Cox regression were used to analyze the relationship between the prognostic factors and survival time in 114 cases of NSCLC. The prognostic factors included clinical-pathological features and serum levels of cytokeratin fragment 19 (Cyfra21-1), CEA, neuron-specific enolase (NSE), CA125, interleukin-2 (IL-2) and soluble interleukin-2 receptors (sIL-2R).
RESULTSKaplan-Meier analysis showed that KPS, sex, disease stage, treatment, Cyfra21-1, sIL-2R and CA125 were related to prognosis. Multivariate analysis indicated that Cyfra21-1, stage and treatment were independent prognostic factors. When Cyfra21-1 > 3.5 mg/L, stage IV and chemotherapy < 3 cycles, the relative risk (RR) was 1.691, 2.229 and 3.035, respectively. In patients given 3 or more cycles of chemotherapy, serum Cyfra21-1, sIL-2R and stage at diagnosis were significantly independent prognostic factors. Three of these prognostic factors were used to establish a prognostic index (PI) model based on a simple algorithm: PI = Cyfra21-1 + sIL-2R + stage. The median survival period of patients with 3 or more cycles of chemotherapy were 18 months if PI = 0, 8 months if PI = 1 or 2, and 5 months if PI = 3.
CONCLUSIONThe serum Cyfra21-1, sIL-2R and disease stage in unresectable NSCLC were independent prognostic factors. PI calculated on the basis of Cyfra21-1, sIL-2R and stage is recommended to predict the survival period of NSCLC.
Antigens, Neoplasm ; blood ; Biomarkers, Tumor ; blood ; Carcinoma, Non-Small-Cell Lung ; drug therapy ; mortality ; pathology ; Female ; Follow-Up Studies ; Humans ; Keratin-19 ; Keratins ; Lung Neoplasms ; drug therapy ; mortality ; pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Receptors, Interleukin-2 ; blood ; Survival Rate